Found 28 matching trials
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma N/A GE Healthcare has recently submitted a New Drug Application (NDA) for Ioben...
Show More Status
Approved For Marketing
Learn More & Join Trial
Study of MIBG-I131 in Patients With Well Differentiated Neuroendocrine Tumors PHASE2 This is a single-arm, unicentric, single-stage, phase 2 clinical study of t...
Show More Location
AC Camargo Cancer Center
Learn More & Join Trial
Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG NA Objective: The objective of this pilot study is to characterize the cardiac...
Show More Location
University of Pittsburgh Medical Center
Learn More & Join Trial
The Leiden Nonischemic Cardiomyopathy Study N/A Rationale: Sudden cardiac death, mainly caused by ventricular arrhythmias (...
Show More Location
Dept. of Cardiology, Leiden University Medical Center
Learn More & Join Trial
MIBG in Aging and Neurologic Disorders PHASE4 The purpose of the study is to investigate the use of a special radioactive...
Show More Status
Enrolling By Invitation
Location
Mayo Clinic in Rochester
Learn More & Join Trial
Irinotecan and Temozolomide in Treating Young Patients With Recurrent Neuroblastoma PHASE2 RATIONALE: Drugs used in chemotherapy, such as irinotecan and temozolomide,...
Show More Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Learn More & Join Trial
High-Dose Iodine I 131 Metaiodobenzylguanidine, Topotecan, and Peripheral Stem Cell Transplant in Treating Young Patients With Relapsed Stage 4 Neuroblastoma or Primary Resistant High-Risk Neuroblastoma PHASE2 RATIONALE: Radioisotope therapy, such as iodine I 131 metaiodobenzylguanidi...
Show More Location
Multiple Locations
Learn More & Join Trial
124I-Metaiodobenzylguanidine (MIBG) PET/CT Diagnostic Imaging and Dosimetry for Patients With Neuroblastoma: A Pilot Study EARLY_PHASE1 This is a pilot study with the primary purpose to describe organ dosimetry ...
Show More Location
University of California, San Francisco
Learn More & Join Trial
hu14.18-Interleukin-2 Fusion Protein in Treating Young Patients With Recurrent or Refractory Neuroblastoma PHASE2 RATIONALE: Biological therapies such as hu14.18-interleukin-2 fusion protei...
Show More Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Learn More & Join Trial
123I-mIBG SPECT Imaging PHASE3 This study is being done with a radioisotope, 123I-mIBG (Adreview), to deve...
Show More Location
University of Ottawa Heart Institute
Learn More & Join Trial